{"Abstract": [0], "Cholangiocarcinoma": [1], "(CCA)": [2], "includes": [3], "a": [4], "cluster": [5], "of": [6, 18, 31, 38, 44, 64, 73, 91, 104, 121, 154, 173, 188], "highly": [7, 50], "heterogeneous": [8], "biliary": [9, 20], "malignant": [10], "tumours": [11, 46, 123], "that": [12, 132], "can": [13], "arise": [14], "at": [15, 93], "any": [16], "point": [17], "the": [19, 88, 94, 102, 105, 109, 119, 148, 152, 163, 186, 191], "tree.": [21], "Their": [22], "incidence": [23], "is": [24, 78, 85, 145, 197], "increasing": [25, 112], "globally,": [26], "currently": [27], "accounting": [28], "for": [29, 151, 190], "~15%": [30], "all": [32, 65], "primary": [33], "liver": [34], "cancers": [35], "and": [36, 53, 82, 97, 124, 130, 160, 176, 183], "~3%": [37], "gastrointestinal": [39], "malignancies.": [40], "The": [41, 70], "silent": [42], "presentation": [43], "these": [45, 122], "combined": [47], "with": [48], "their": [49, 59], "aggressive": [51], "nature": [52], "refractoriness": [54], "to": [55, 58, 117, 125, 135, 158], "chemotherapy": [56], "contribute": [57], "alarming": [60], "mortality,": [61], "representing": [62], "~2%": [63], "cancer-related": [66], "deaths": [67], "worldwide": [68], "yearly.": [69], "current": [71], "diagnosis": [72], "CCA": [74, 189], "by": [75, 147], "non-invasive": [76], "approaches": [77], "not": [79], "accurate": [80], "enough,": [81], "histological": [83], "confirmation": [84], "necessary.": [86], "Furthermore,": [87, 185], "high": [89], "heterogeneity": [90], "CCAs": [92], "genomic,": [95], "epigenetic": [96, 177], "molecular": [98, 179], "levels": [99], "severely": [100], "compromises": [101], "efficacy": [103], "available": [106], "therapies.": [107], "In": [108, 139], "past": [110], "decade,": [111], "efforts": [113], "have": [114], "been": [115], "made": [116], "understand": [118], "complexity": [120], "develop": [126], "new": [127], "diagnostic": [128], "tools": [129], "therapies": [131], "might": [133], "help": [134], "improve": [136], "patient": [137], "outcomes.": [138], "this": [140], "expert": [141], "Consensus": [142], "Statement,": [143], "which": [144], "endorsed": [146], "European": [149], "Network": [150], "Study": [153], "Cholangiocarcinoma,": [155], "we": [156], "aim": [157], "summarize": [159], "critically": [161], "discuss": [162], "latest": [164], "advances": [165], "in": [166], "CCA,": [167], "mostly": [168], "focusing": [169], "on": [170], "classification,": [171], "cells": [172], "origin,": [174], "genetic": [175], "abnormalities,": [178], "alterations,": [180], "biomarker": [181], "discovery": [182], "treatments.": [184], "horizon": [187], "next": [192], "decade": [193], "from": [194], "2020": [195], "onwards": [196], "highlighted.": [198]}